Nanoparticles have unique properties that make them highly useful in various applications, from drug delivery to imaging and cancer treatment. However, their small size and high reactivity can also cause unintended biological effects. Monitoring LDH release provides a quick and reliable method to evaluate the cytotoxicity of nanoparticles, ensuring their safety and efficacy in biomedical applications.
